Baseline serum metabolites predict fractures in individuals who were Black and had type 2 diabetes - Summary - MDSpire

Baseline serum metabolites predict fractures in individuals who were Black and had type 2 diabetes

  • By

  • Carolyn Chlebek

  • Valerie Bussberg

  • Niven R. Narain

  • Michael A. Kiebish

  • Yu-Hua Tseng

  • Clifford J. Rosen

  • Matthew D. Lynes

  • June 2, 2026

Share

Objective:

To identify serum metabolite differences at baseline that may predict fracture risk in Black individuals with Type 2 Diabetes Mellitus (T2D).

Key Findings:
  • 7,8-dihydrofolate levels were significantly higher in participants who later fractured.
  • Several metabolites related to the tricarboxylic acid cycle were reduced in participants who later fractured.
Interpretation:

Remove this section.

Limitations:
  • The study focuses exclusively on Black individuals, limiting generalizability to other populations.
  • The analysis is exploratory and based on a relatively small clinical dataset.
Conclusion:

Rephrase to avoid unsupported claims, focusing on the need for further research as stated in the source.

Original Source(s)

Baseline serum metabolites predict fractures in individuals who were Black and had type 2 diabetes

  • by Carolyn Chlebek, Valerie Bussberg, Niven R. Narain, Michael A. Kiebish, Yu-Hua Tseng, Clifford J. Rosen, Matthew D. Lynes

  • June 2, 2026

Related Content

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

Metformin’s Potential Role in PCO

Common diabetes therapy reaches intraocular lens tissue and may help limit posterior capsule opacification, says newly published data

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort